Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...

Bitcoin miners are increasingly pivoting to AI data centers, as declining profitability from events like last year's halving ...

Sanofi recently announced that its investigational radiopharmaceutical therapy, AlphaMedix™, met all primary efficacy endpoints in a Phase II trial for patients with unresectable or metastatic ...